Edition:
United Kingdom

Merus NV (MRUS.OQ)

MRUS.OQ on NASDAQ Stock Exchange Global Market

19.00USD
21 Sep 2018
Change (% chg)

$-0.36 (-1.86%)
Prev Close
$19.36
Open
$19.69
Day's High
$19.69
Day's Low
$19.00
Volume
36,018
Avg. Vol
14,277
52-wk High
$26.49
52-wk Low
$14.24

Chart for

About

Merus NV is a biotechnology company based in the Netherlands. The Company develops differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Biclonics format. Its products include, among others, MCLA-134 that is designed to bind to a combination of two immunomodulatory targets... (more)

Overall

Beta: --
Market Cap(Mil.): $404.73
Shares Outstanding(Mil.): 19.39
Dividend: --
Yield (%): --

Financials

  MRUS.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -6.12 -- --
ROI: -58.10 1.79 14.61
ROE: -113.41 3.28 16.33

BRIEF-Merus Q4 Loss Per Share EUR 0.73

* MERUS ANNOUNCES RECENT CORPORATE DEVELOPMENTS AND FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2017

26 Apr 2018

Earnings vs. Estimates